Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases

Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases

<p>Supplementary Table S1</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Noor Jailkhani (16015810) (author)
Andere auteurs:	Karl R. Clauser (16015813) (author), Howard H. Mak (14958336) (author), Steffen Rickelt (14942629) (author), Chenxi Tian (16015816) (author), Charles A. Whittaker (15038249) (author), Kenneth K. Tanabe (16015819) (author), Stephen R. Purdy (16015822) (author), Steven A. Carr (14942649) (author), Richard O. Hynes (14942641) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Tumor Biology Molecular and Cellular Biology Immuno-oncology Methods and Technology Breast Cancer Imaging Positron emission tomography (PET) Small animal imaging Immunology Antibodies/immunoconjugates Proteomics Tumor Microenvironment
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
door: Noor Jailkhani (16015810)
Gepubliceerd in: (2025)

Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
door: Noor Jailkhani (16015810)
Gepubliceerd in: (2025)

Supplementary Video S1 from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
door: Xiaojiang Duan (15439264)
Gepubliceerd in: (2025)

Supplementary Video S2A from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
door: Xiaojiang Duan (15439264)
Gepubliceerd in: (2025)

Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
door: Xiaojiang Duan (15439264)
Gepubliceerd in: (2025)

Supplementary Video S2C from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
door: Xiaojiang Duan (15439264)
Gepubliceerd in: (2025)

FigureS1 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS10 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS2 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS3 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS4 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS5 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS6 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS7 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS8 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

FigureS9 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

Supplementary MovieS 1a from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

Supplementary MovieS1b from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

Supplementary MovieS1c from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

Supplementary MovieS1d from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

Supplementary MovieS2a from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

Supplementary MovieS2b from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

Supplementary MovieS2c from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
door: Jonathan Chou (14957015)
Gepubliceerd in: (2025)

Supplementary Data S1 from Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
door: Steven B. Maron (15044607)
Gepubliceerd in: (2025)

Alternative Ion-Pairing Modifiers Should Be Investigated in Low-Input and Single-Cell Proteomics
door: Colten D. Eberhard (17729446)
Gepubliceerd in: (2025)

Quantitative Proteomics Links Mitochondrial Dysfunction to Metabolic Changes and Epithelial Differentiation Defects in Hyperoxia-Exposed Neonatal Airway Cells
door: Abhrajit Ganguly (21540245)
Gepubliceerd in: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
door: Marwa Zafarullah (12527002)
Gepubliceerd in: (2025)

Figure 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
door: Friederike Hesse (14958870)
Gepubliceerd in: (2025)

Figure 2 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
door: Friederike Hesse (14958870)
Gepubliceerd in: (2025)

Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
door: Friederike Hesse (14958870)
Gepubliceerd in: (2025)

Figure 4 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
door: Friederike Hesse (14958870)
Gepubliceerd in: (2025)

Figure 5 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
door: Friederike Hesse (14958870)
Gepubliceerd in: (2025)

Figure 6 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
door: Friederike Hesse (14958870)
Gepubliceerd in: (2025)

Figure 7 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
door: Friederike Hesse (14958870)
Gepubliceerd in: (2025)

Table 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
door: Friederike Hesse (14958870)
Gepubliceerd in: (2025)

Figure 1 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
door: Vinton W.T. Cheng (15020397)
Gepubliceerd in: (2025)

Figure 2 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
door: Vinton W.T. Cheng (15020397)
Gepubliceerd in: (2025)

Figure 3 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
door: Vinton W.T. Cheng (15020397)
Gepubliceerd in: (2025)

Figure 4 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
door: Vinton W.T. Cheng (15020397)
Gepubliceerd in: (2025)

Figure 5 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
door: Vinton W.T. Cheng (15020397)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_9kd4tsv6vkum2js6l3n5a0aoap